tradingkey.logo
tradingkey.logo
검색

Rockwell Medical Inc

RMTI
관심 목록에 추가
0.792USD
-0.004-0.55%
종가 05/15, 16:00ET시세는 15분 지연됩니다
31.26M시가총액
손실P/E TTM

Rockwell Medical Inc

0.792
-0.004-0.55%

자세한 내용은 Rockwell Medical Inc 회사

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.

Rockwell Medical Inc 정보

종목 코드 RMTI
회사 이름Rockwell Medical Inc
상장일Jan 27, 1998
CEOStrobeck (Mark)
직원 수244
유형Ordinary Share
회계 연도 종료Jan 27
주소30142 Wixom Road
도시WIXOM
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호48393
전화18004493353
웹사이트https://www.rockwellmed.com/
종목 코드 RMTI
상장일Jan 27, 1998
CEOStrobeck (Mark)

Rockwell Medical Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
--
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
145.45K
+3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
125.68K
-1.94%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
--
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.95K
-165.85%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
61.85K
-124.77%
Mr. Jesse Neri
Mr. Jesse Neri
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
18.68K
-449.49%
Mr. Robert S. Radie
Mr. Robert S. Radie
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Allen R. Nissenson, M.D.
Dr. Allen R. Nissenson, M.D.
Independent Director
Independent Director
--
--
Ms. Heather R. Hunter
Ms. Heather R. Hunter
Chief Operating Officer
Chief Operating Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
--
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
145.45K
+3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
125.68K
-1.94%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
--
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.95K
-165.85%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
61.85K
-124.77%

수익 분석

FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Concentrate Products
68.93M
0.00%
Drug Products
325.00K
0.00%
지역별USD
이름
수익
비율
United States
60.36M
0.00%
Rest of World
8.90M
0.00%
사업별
지역별
사업별USD
이름
수익
비율
Concentrate Products
68.93M
0.00%
Drug Products
325.00K
0.00%

주식 보유 통계

마지막 업데이트: Thu, May 14
마지막 업데이트: Thu, May 14
주주
주주 유형
주주
주주
비율
Irrevocable Larson Family Investment Trust
9.01%
Vanguard Capital Management, LLC
3.00%
Renaissance Technologies LLC
1.19%
Geode Capital Management, L.L.C.
0.92%
Vanguard Fiduciary Trust Co
0.59%
기타
85.29%
주주
주주
비율
Irrevocable Larson Family Investment Trust
9.01%
Vanguard Capital Management, LLC
3.00%
Renaissance Technologies LLC
1.19%
Geode Capital Management, L.L.C.
0.92%
Vanguard Fiduciary Trust Co
0.59%
기타
85.29%
주주 유형
주주
비율
Corporation
9.01%
Investment Advisor
5.96%
Individual Investor
3.30%
Investment Advisor/Hedge Fund
1.63%
Hedge Fund
1.50%
Research Firm
0.28%
Venture Capital
0.16%
기타
78.16%

기관 주식 보유

마지막 업데이트: Wed, Apr 1
마지막 업데이트: Wed, Apr 1
보고 기간
기관 수
보유 주식
비율
변동
2026Q1
98
5.15M
13.04%
-2.20M
2025Q4
93
3.38M
8.58%
-3.83M
2025Q3
98
6.21M
18.04%
-1.88M
2025Q2
119
12.15M
35.56%
-1.45M
2025Q1
124
11.25M
32.97%
-1.96M
2024Q4
123
12.47M
38.59%
-1.21M
2024Q3
113
13.08M
41.13%
+2.79M
2024Q2
102
9.50M
31.23%
+460.06K
2024Q1
118
5.89M
19.90%
-1.12M
2023Q4
118
5.97M
23.48%
-688.25K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Irrevocable Larson Family Investment Trust
3.56M
9.03%
+87.50K
+2.52%
Apr 11, 2025
Renaissance Technologies LLC
468.32K
1.19%
-93.89K
-16.70%
Dec 31, 2025
Geode Capital Management, L.L.C.
364.82K
0.93%
+41.67K
+12.89%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
214.64K
0.54%
-1.45K
-0.67%
Dec 31, 2025
UBS Financial Services, Inc.
139.72K
0.35%
+132.16K
+1749.79%
Dec 31, 2025
Ravich (Mark H)
151.10K
0.38%
+50.00K
+49.45%
May 20, 2025
Cooper (John G)
140.37K
0.36%
-5.08K
-3.49%
Nov 18, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Micro-Cap ETF
비율0.01%
Dimensional US Core Equity 1 ETF
비율0%
DFA Dimensional US Sustainability Core 1 ETF
비율0%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
날짜
배당락일
유형
비율
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
KeyAI